Brooke Alhanti

Apr 27, 2024 | medrxiv.org | Regina Royan |Iyanuoluwa Ayodele |Brian E. Stamm |Brooke Alhanti

RR receives funding from the National Institute of Minority Health and Health Disparities though this work was not supported by this grant. PP receives funding from the National Institutes of Health Agency for Healthcare Research and Quality (AHRQ) (K08HS029208). SP receives funding from the AHRQ (R18HS027264) and National Institute of Neurological Disorders and Stroke (NINDS) (U24NS107233, R25NS125609; U01NS131797).

Feb 9, 2024 | jamanetwork.com | Kevin N. Sheth |Nicole Solomon |Brooke Alhanti |Steven R. Messé

Key PointsQuestion  Is door-to-treatment time associated with improved outcomes in patients with anticoagulation-associated intracerebral hemorrhage receiving reversal interventions? Findings  In this cohort study including 9492 patients, a door-to-treatment time of 60 minutes or less was associated with lower mortality and hospice transfers. White race and stroke severity were associated with faster administration of reversal interventions.

Jan 24, 2024 | jamanetwork.com | Sarah Snow |Brooke Alhanti |Pamela Douglas

Key PointsQuestion  Have the proportions of women and individuals from underrepresented racial and ethnic groups in cardiovascular disease and cardiovascular subspecialty fellowships increased over time? Findings  In this cross-sectional study, percentages of women trainees in cardiovascular disease and interventional cardiology fellowships significantly increased from 2008 to 2022.